- Home
- WNW vs ADXN Comparison
WNW vs ADXN Comparison
Compare WNW & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- ADXN
- Stock Information
- Founded
- WNW 2015
- ADXN 2002
- Country
- WNW China
- ADXN Switzerland
- Employees
- WNW N/A
- ADXN N/A
- Industry
- WNW Catalog/Specialty Distribution
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- ADXN Health Care
- Exchange
- WNW Nasdaq
- ADXN Nasdaq
- Market Cap
- WNW 10.1M
- ADXN 8.2M
- IPO Year
- WNW 2020
- ADXN N/A
- Fundamental
- Price
- WNW $1.68
- ADXN $7.45
- Analyst Decision
- WNW
- ADXN Strong Buy
- Analyst Count
- WNW 0
- ADXN 1
- Target Price
- WNW N/A
- ADXN $30.00
- AVG Volume (30 Days)
- WNW 51.2K
- ADXN 7.7K
- Earning Date
- WNW 11-15-2024
- ADXN 04-07-2025
- Dividend Yield
- WNW N/A
- ADXN N/A
- EPS Growth
- WNW N/A
- ADXN N/A
- EPS
- WNW N/A
- ADXN 0.06
- Revenue
- WNW $380,345.00
- ADXN $701,260.00
- Revenue This Year
- WNW N/A
- ADXN N/A
- Revenue Next Year
- WNW N/A
- ADXN N/A
- P/E Ratio
- WNW N/A
- ADXN $0.89
- Revenue Growth
- WNW N/A
- ADXN N/A
- 52 Week Low
- WNW $1.53
- ADXN $6.67
- 52 Week High
- WNW $70.00
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- WNW 28.22
- ADXN 47.90
- Support Level
- WNW $1.53
- ADXN $7.16
- Resistance Level
- WNW $3.34
- ADXN $8.05
- Average True Range (ATR)
- WNW 0.29
- ADXN 0.45
- MACD
- WNW 0.15
- ADXN -0.02
- Stochastic Oscillator
- WNW 8.29
- ADXN 51.22
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments: Clean Food Platform; Restaurant; and Others. The company generates the majority of its revenue from Technical services.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.